BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
fortis malar hospitals limited stock

FORTIS MALAR HOSPITALS LIMITED Share Price

62 -0.20 (-0.32%)
Dec 13 2024 03:29 PM Healthcare NSE: FORTISMLR

FORTIS MALAR HOSPITALS LIMITED Share Price Update

As of the latest trading session, FORTIS MALAR HOSPITALS LIMITED share price is currently at 62, which is down by -0.20 from its previous closing. Today, the stock has fluctuated between 61.10 and 63.75. Over the past year, FORTIS MALAR HOSPITALS LIMITED has achieved a return of -0.12 %. In the last month alone, the return has been 18.89 %. Read More...

FORTIS MALAR HOSPITALS LIMITED Performance

Day Range

Low61.10 High63.75
62.05

52 Week Range

Low 44.00 High 107.94
62.05

FORTIS MALAR HOSPITALS LIMITED Share Price

523696

FORTISMLR

img img img img
No Data Available

Open Price

63.75

Prev. Close

62.20

Volume (Shares)

23972.00

Total traded value

14.88

Upper Circuit

74.64

Lower Circuit

49.76

Note: The current prices & values are delayed, Login to your account for live updates.

FORTIS MALAR HOSPITALS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 116.19
PE Ratio (TTM) 2.23
Book Value / Share 15.77
Beta 0.40
ROE -6.99%
EPS (TTM) 0.00
Dividend Yield 68.56%
Net Profit Qtr (Cr) 0.09

FORTIS MALAR HOSPITALS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.46
Net Profit 0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.05
EBITDA 0.09
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.89
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 5.52
Operating Expense 6.47
Net Profit 56.04
Net Profit Margin (%) 1015.21
Earnings Per Share (EPS) 29.90
EBITDA 62.15
Effective Tax Rate (%) 7.69
Particulars DEC 2023 (Values in Cr)
Revenue 17.58
Operating Expense 22.83
Net Profit -4.01
Net Profit Margin (%) -22.81
Earnings Per Share (EPS) -2.14
EBITDA 0.16
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 18.15
Operating Expense 22.25
Net Profit -1.81
Net Profit Margin (%) -9.97
Earnings Per Share (EPS) -0.96
EBITDA 2.21
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 59.01
Operating Expense 73.86
Net Profit 47.28
Net Profit Margin (%) 80.12
Earnings Per Share (EPS) 25.23
EBITDA 65.61
Effective Tax Rate (%) 8.98
Particulars MAR 2023 (Values in Cr)
Revenue 85.95
Operating Expense 99.59
Net Profit -15.53
Net Profit Margin (%) -18.06
Earnings Per Share (EPS) -8.29
EBITDA 11.14
Effective Tax Rate (%) -119.49
Particulars MAR 2022 (Values in Cr)
Revenue 86.18
Operating Expense 101.82
Net Profit -8.31
Net Profit Margin (%) -9.64
Earnings Per Share (EPS) -4.43
EBITDA 10.77
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 69.24
Operating Expense 95.64
Net Profit -8.01
Net Profit Margin (%) -11.56
Earnings Per Share (EPS) -4.28
EBITDA 8.61
Effective Tax Rate (%) 30.07
Particulars MAR 2020 (Values in Cr)
Revenue 111.87
Operating Expense 134.95
Net Profit -9.06
Net Profit Margin (%) -8.09
Earnings Per Share (EPS) -4.83
EBITDA 8.18
Effective Tax Rate (%) 25.49
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.36
ROE % -9.12
ROCE % -3.24
Total Debt to Total Equity 0.27
EBITDA Margin 9.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.21
ROE % -21.45
ROCE % -0.75
Total Debt to Total Equity 0.69
EBITDA Margin 13.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.72
ROE % -9.79
ROCE % -1.19
Total Debt to Total Equity 0.65
EBITDA Margin 12.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.31
ROE % -15.90
ROCE % -7.05
Total Debt to Total Equity 0.66
EBITDA Margin 2.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 51.40
ROE % -8.81
ROCE % -3.05
Total Debt to Total Equity 0.32
EBITDA Margin 7.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.22
ROE % -6.99
ROCE % -1.52
Total Debt to Total Equity 0.27
EBITDA Margin 13.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 33.03
ROE % -22.20
ROCE % -0.81
Total Debt to Total Equity 0.71
EBITDA Margin 12.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.57
ROE % -10.10
ROCE % -1.25
Total Debt to Total Equity 0.67
EBITDA Margin 12.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 46.18
ROE % -16.42
ROCE % -7.24
Total Debt to Total Equity 0.67
EBITDA Margin 2.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 50.34
ROE % -9.15
ROCE % -3.27
Total Debt to Total Equity 0.32
EBITDA Margin 7.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 108.22
Total Assets 115.87
Total Liabilities 115.87
Total Equity 109.46
Share Outstanding 18741759
Price to Book Ratio 0.80
Return on Assets (%) 39.11
Return on Capital (%) 41.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.43
Total Assets 137.99
Total Liabilities 137.99
Total Equity 64.17
Share Outstanding 18741759
Price to Book Ratio 1.44
Return on Assets (%) -11.21
Return on Capital (%) -24.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.55
Total Assets 160.91
Total Liabilities 160.91
Total Equity 80.13
Share Outstanding 18741759
Price to Book Ratio 1.39
Return on Assets (%) -5.14
Return on Capital (%) -10.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.56
Total Assets 169.09
Total Liabilities 169.09
Total Equity 88.74
Share Outstanding 18741759
Price to Book Ratio 1.20
Return on Assets (%) -4.65
Return on Capital (%) -8.87
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 43.25
Total Assets 193.54
Total Liabilities 193.54
Total Equity 96.40
Share Outstanding 18741759
Price to Book Ratio 0.85
Return on Assets (%) -4.59
Return on Capital (%) -9.22
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.10
Total Assets 115.38
Total Liabilities 115.38
Total Equity 109.20
Share Outstanding 18741759
Price to Book Ratio 0.80
Return on Assets (%) 40.97
Return on Capital (%) 43.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.30
Total Assets 135.69
Total Liabilities 135.69
Total Equity 61.95
Share Outstanding 18741759
Price to Book Ratio 1.44
Return on Assets (%) -11.44
Return on Capital (%) -25.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 10.48
Total Assets 158.67
Total Liabilities 158.67
Total Equity 77.97
Share Outstanding 18741759
Price to Book Ratio 1.39
Return on Assets (%) -5.23
Return on Capital (%) -10.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.60
Total Assets 166.98
Total Liabilities 166.98
Total Equity 86.61
Share Outstanding 18741759
Price to Book Ratio 1.20
Return on Assets (%) -4.79
Return on Capital (%) -9.25
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 41.71
Total Assets 191.41
Total Liabilities 191.41
Total Equity 94.42
Share Outstanding 18741759
Price to Book Ratio 0.85
Return on Assets (%) -4.73
Return on Capital (%) -9.59
Particulars MAR 2024 (Values in Cr)
Net Income 50.00
Cash from Operations -2.27
Cash from Investing 119.70
Cash from Financing -10.85
Net change in Cash 101.54
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income -7.00
Cash from Operations 5.52
Cash from Investing 0.49
Cash from Financing -12.65
Net change in Cash -6.54
Free Cash Flow 7.40
Particulars MAR 2022 (Values in Cr)
Net Income -8.26
Cash from Operations 7.56
Cash from Investing 8.23
Cash from Financing -10.10
Net change in Cash 4.97
Free Cash Flow 8.96
Particulars MAR 2021 (Values in Cr)
Net Income -11.31
Cash from Operations -12.95
Cash from Investing -27.51
Cash from Financing -7.24
Net change in Cash -35.62
Free Cash Flow -12.42
Particulars MAR 2020 (Values in Cr)
Net Income -11.93
Cash from Operations 3.86
Cash from Investing 49.88
Cash from Financing -11.56
Net change in Cash 38.01
Free Cash Flow 7.17
Particulars MAR 2024 (Values in Cr)
Net Income 51.94
Cash from Operations -2.20
Cash from Investing 119.62
Cash from Financing -10.85
Net change in Cash 101.55
Free Cash Flow 0.09
Particulars MAR 2023 (Values in Cr)
Net Income -7.07
Cash from Operations 5.51
Cash from Investing 0.43
Cash from Financing -12.65
Net change in Cash -6.60
Free Cash Flow 7.39
Particulars MAR 2022 (Values in Cr)
Net Income -8.30
Cash from Operations 7.47
Cash from Investing 8.17
Cash from Financing -10.10
Net change in Cash 4.87
Free Cash Flow 8.88
Particulars MAR 2021 (Values in Cr)
Net Income -11.46
Cash from Operations -12.85
Cash from Investing -27.60
Cash from Financing -7.24
Net change in Cash -36.04
Free Cash Flow -12.32
Particulars MAR 2020 (Values in Cr)
Net Income -12.15
Cash from Operations 4.34
Cash from Investing 48.30
Cash from Financing -11.56
Net change in Cash 36.47
Free Cash Flow 7.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 88.28 13.93 104442.30 5286.00 / 7545.10
SHREE PACETRONIX LTD. 123.75 19.93 3.31 44.54 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.60 0.00 5.31 57.59 5.79 / 12.46
VIMTA LABS LIMITED 956.50 39.79 6.19 2124.70 390.60 / 981.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 93.01 12.75 104442.30 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 52.25 0.00 -27.99 39.03 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5501.45 29.84 6.18 6018.59 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 62.50
  • 26 Days 58.30
  • 10 Days 61.40
  • 50 Days 57.50
  • 12 Days 60.80
  • 100 Days 59.00
  • 20 Days 59.00
  • 200 Days 55.20
62.52
PIVOT
First Resistance 63.18
Second Resistance 64.17
Third Resistance 64.83
First Support 61.53
Second Support 60.87
Third Support 59.88
RSI 66.94
MACD 2.50
Commodity Channel Index (CCI) 67.17
ADX 47.30
Williams % R -25.21

Over 1 Month

down

18.89

Over 3 Months

down

3.88

Over 6 Months

down

-8.83

Over 1 Year

down

-0.12

Over 3 Years

down

-0.79

Over 5 Years

down

4.41

FORTIS MALAR HOSPITALS LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

FORTIS MALAR HOSPITALS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
37.22
Promoter Holdings
62.7
FII
0.0
DII
0.07
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Fortis Hospitals Limited Shareholding of Promoter and Promoter Group 1.1752402E7 62.71
Ruckmani Natarajan Public Shareholding 387960.0 2.07
Nithya Ramamurthy Public Shareholding 362901.0 1.94
Sunita Kantilal Vardhan Public Shareholding 247934.0 1.32
A M Gopalan Public Shareholding 231028.0 1.23

FORTIS MALAR HOSPITALS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2015-09-14 0.5 Final 2015-09-16 Equity shares 2013-09-19 0.5 Interim 2013-09-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About FORTIS MALAR HOSPITALS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by FORTIS MALAR HOSPITALS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Fortis Malar Hospitals Ltd?

Answer Field

The share price of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 62.05.

What is the Market Cap of Fortis Malar Hospitals Ltd?

Answer Field

The market cap of Fortis Malar Hospitals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,16.30 Cr. as of now.

What is the 52 Week High and Low of Fortis Malar Hospitals Ltd?

Answer Field

The 52 Week High and Low of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 107.94 and ₹ 44.00.

How to Buy Fortis Malar Hospitals Ltd share?

Answer Field

You can trade in Fortis Malar Hospitals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Fortis Malar Hospitals Ltd?

Answer Field

The 1 year returns on the stock has been -0.12%.

What is the Current Share Price of Fortis Malar Hospitals Ltd?

Answer Field

Fortis Malar Hospitals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 62.05 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Fortis Malar Hospitals Ltd Share?

Answer Field

The market cap of Fortis Malar Hospitals Ltd for NSE ₹ 0.0 & for BSE ₹ 1,16.30 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Fortis Malar Hospitals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Fortis Malar Hospitals Ltd share is 2.23.

What is the PB ratio of Fortis Malar Hospitals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Fortis Malar Hospitals Ltd share is 15.77.

How to Buy Fortis Malar Hospitals Ltd Share?

Answer Field

You can trade in Fortis Malar Hospitals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fortis Malar Hospitals Ltd Share on Bajaj Broking App?

Answer Field

To buy Fortis Malar Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fortis Malar Hospitals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader